









市场行情
/
股票
/
nasdaq-mdxg
/

MiMedx Group Inc

MDXG

6.930USD

+0.070+1.02%

收盘 12/05, 16:00（美东）报价延迟15分钟

1.03B总市值

25.13市盈率 TTM



MiMedx Group Inc

6.930

+0.070+1.02%

概览公司财务分析

概览

公司

财务

分析

关于 MiMedx Group Inc 公司

MiMedx Group, Inc. 是一家胎盘生物制剂公司。该公司致力于开发和分销具有专利保护工艺的胎盘组织异体移植，服务于医疗保健的多个领域。其产品组合类别包括伤口护理产品以及外科和其他产品。其伤口护理产品包括 EPIFIX、EPICORD 和 EPIEFFECT，这些产品均用于外用，例如用于高级伤口护理应用。其外科和其他产品包括 AMNIOFIX、AMNIOCORD 和 AMNIOEFFECT，这些产品适用于各种应用和外科环境，包括下肢修复、整形外科、血管外科和多种骨科修复和重建。该公司的平台技术包括源自人胎盘膜的组织异体移植、源自人脐带的组织异体移植以及源自人胎盘的颗粒细胞外基质。

MiMedx Group Inc简介



公司代码MDXG

公司名称MiMedx Group Inc

上市日期Aug 20, 2007

CEOMr. Joseph H. (Joe) Capper

员工数量837

证券类型Ordinary Share

年结日Aug 20

公司地址1775 W Oak Commons Court, Ne

城市MARIETTA

上市交易所NASDAQ Capital Market Consolidated

国家United States of America

邮编30062

电话17706519100

网址https://mimedx.com/

公司代码MDXG

上市日期Aug 20, 2007

CEOMr. Joseph H. (Joe) Capper

MiMedx Group Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Joseph H. (Joe) Capper

Chief Executive Officer, Director

529.53K

+60.69%

Mr. James L. Bierman

Independent Director

212.77K

+15.53%

Ms. Ricci S. Whitlow

Executive Vice President, Chief Operating Officer

190.25K

-57.15%

Dr. Cato T. Laurencin, M.D., Ph.D.

Independent Director

181.92K

+18.66%

Ms. Dorothy E. Puhy

Independent Director

57.60K

+98.69%

Ms. Kimberly (Kim) Maersk-Moller

Chief Commercial Officer

30.74K

-65.48%

Mr. William A. (Bill) Hawkins, III

Independent Director

Mr. Douglas C. Rice

Chief Financial Officer

Mr. K. Todd Newton

Independent Director

Dr. M. Kathleen Behrens Wilsey, Ph.D.

Independent Chairman of the Board

名称

名称/职务

职务

持股

持股变动

Mr. Joseph H. (Joe) Capper

Chief Executive Officer, Director

529.53K

+60.69%

Mr. James L. Bierman

Independent Director

212.77K

+15.53%

Ms. Ricci S. Whitlow

Executive Vice President, Chief Operating Officer

190.25K

-57.15%

Dr. Cato T. Laurencin, M.D., Ph.D.

Independent Director

181.92K

+18.66%

Ms. Dorothy E. Puhy

Independent Director

57.60K

+98.69%

Ms. Kimberly (Kim) Maersk-Moller

Chief Commercial Officer

30.74K

-65.48%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

业务USD

名称

营收

占比

Advanced Wound Care

64.48M

65.39%

Surgical

34.13M

34.61%

由于公司未披露，未能获取相关数据

业务

地区

业务USD

名称

营收

占比

Advanced Wound Care

64.48M

65.39%

Surgical

34.13M

34.61%

股东统计

更新时间: 11月16日周日

持股股东

股东类型

持股股东

占比

EW Healthcare Partners

19.04%

BlackRock Institutional Trust Company, N.A.

5.90%

Trigran Investments, Inc.

5.20%

The Vanguard Group, Inc.

4.58%

First Light Asset Management, LLC

2.47%

其他

62.82%

持股股东

占比

EW Healthcare Partners

19.04%

BlackRock Institutional Trust Company, N.A.

5.90%

Trigran Investments, Inc.

5.20%

The Vanguard Group, Inc.

4.58%

First Light Asset Management, LLC

2.47%

其他

62.82%

股东类型

持股股东

占比

Investment Advisor

19.22%

Venture Capital

19.04%

Investment Advisor/Hedge Fund

18.75%

Hedge Fund

11.78%

Research Firm

2.14%

Individual Investor

1.79%

Pension Fund

0.62%

Bank and Trust

0.36%

Insurance Company

0.03%

其他

26.28%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

443

104.90M

70.83%

-3.83M

2025Q2

451

106.45M

71.95%

-3.98M

2025Q1

460

106.92M

72.40%

-5.30M

2024Q4

455

107.57M

73.21%

-3.01M

2024Q3

429

103.18M

70.48%

-6.90M

2024Q2

424

100.59M

68.44%

-3.52M

2024Q1

405

106.53M

74.65%

+1.42M

2023Q4

391

100.91M

86.85%

+27.80M

2023Q3

385

72.00M

62.20%

-22.83M

2023Q2

375

65.55M

56.85%

-21.21M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

EW Healthcare Partners

28.20M

19.06%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

8.81M

5.95%

+232.31K

+2.71%

Jun 30, 2025

Trigran Investments, Inc.

8.39M

5.67%

+790.90K

+10.41%

Jun 30, 2025

The Vanguard Group, Inc.

6.93M

4.69%

+246.16K

+3.68%

Jun 30, 2025

First Light Asset Management, LLC

1.93M

1.3%

-1.53M

-44.18%

Jun 30, 2025

State Street Investment Management (US)

3.47M

2.34%

+5.97K

+0.17%

Jun 30, 2025

Geode Capital Management, L.L.C.

2.84M

1.92%

-69.37K

-2.38%

Jun 30, 2025

Paradigm Capital Management, Inc.

4.45M

3.01%

-231.10K

-4.93%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

2.28M

1.54%

+274.09K

+13.64%

Jun 30, 2025

Cannell Capital, LLC

2.07M

1.4%

-59.03K

-2.77%

Jun 30, 2025

持股ETF



更新时间: 12月2日周二

机构名称

占比

Invesco NASDAQ Future Gen 200 ETF

0.58%

Janus Henderson Small Cap Growth Alpha ETF

0.56%

First Trust Small Cap Growth AlphaDEX Fund

0.3%

iShares Micro-Cap ETF

0.17%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.16%

Franklin US Small Cap Multifactor Index ETF

0.15%

Vanguard US Quality Factor ETF

0.14%

WisdomTree US SmallCap Quality Growth Fund

0.14%

VictoryShares Small Cap Free Cash Flow ETF

0.12%

State Street SPDR S&P Biotech ETF

0.12%

Invesco NASDAQ Future Gen 200 ETF

占比0.58%

Janus Henderson Small Cap Growth Alpha ETF

占比0.56%

First Trust Small Cap Growth AlphaDEX Fund

占比0.3%

iShares Micro-Cap ETF

占比0.17%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

占比0.16%

Franklin US Small Cap Multifactor Index ETF

占比0.15%

Vanguard US Quality Factor ETF

占比0.14%

WisdomTree US SmallCap Quality Growth Fund

占比0.14%

VictoryShares Small Cap Free Cash Flow ETF

占比0.12%

State Street SPDR S&P Biotech ETF

占比0.12%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

MiMedx Group Inc的前五大股东是谁？



MiMedx Group Inc 的前五大股东如下：
EW Healthcare Partners持有股份：28.20M，占总股份比例：19.06%。
BlackRock Institutional Trust Company, N.A.持有股份：8.81M，占总股份比例：5.95%。
Trigran Investments, Inc.持有股份：8.39M，占总股份比例：5.67%。
The Vanguard Group, Inc.持有股份：6.93M，占总股份比例：4.69%。
First Light Asset Management, LLC持有股份：1.93M，占总股份比例：1.30%。